Digital Diabetes Management Market to Reach USD 19.98 billion by 2024: Emerging Medical Innovations

Illinois, United States, 2021-Aug-03 — /EPR Network/ —

This report aims to provide detailed insights into the global digital diabetes management market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Don’t miss out on business opportunities in Digital Diabetes Management Market

Revenue Growth Analysis:

The Digital Diabetes Management Industry is projected to reach USD 19.9 billion by 2024 from an estimated USD 6.8 billion in 2019, at a CAGR of 23.8%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893

Key Factors Driving Market Growth:

The major factors driving the growth of this market include the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps.

By product & service, the devices segment accounted for the largest share of the Digital Diabetes Management Market 

Based on product & service, the market is divided into devices, apps, data management software & platforms, and services. The devices segment accounted for the largest market share in 2018. The growing demand for wireless and wearable devices for diabetes management, growing acceptance of smart insulin pumps & pens for insulin delivery, technological innovations & digital advancements in devices, and increasing awareness about continuous glucose monitoring in patients are the key factors driving the growth of the devices segment.

Wearable devices segment to witness the highest growth in the digital diabetes management devices market, by type

Based on type, the digital diabetes management devices industry is segmented into wearable devices and handheld devices. The wearable devices segment accounted for the largest share of the digital diabetes management devices market in 2018. The large share of this segment can be attributed to the increasing number of regulatory approvals for CGM systems; technological advancements such as closed-loop pump systems, smart insulin patches, and other pipeline devices; and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery in diabetes management.

North America, the largest regional market for digital diabetes management 

North America accounted for the largest share of the Digital Diabetes Management Market in 2018, followed by Europe and the Asia Pacific. Factors such as growing adoption of connected diabetes management devices, high adoption of diabetes management apps, growing demand for integrated hybrid closed-loop systems, favorable reimbursement policies, and government initiatives to promote digital health in the region are driving the growth of the Digital Diabetes Management Industry in North America.

Request Sample Report@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=144725893

Prominent players in the Digital Diabetes Management Market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).

Medtronic is the leading player in the digital diabetes management industry. The company’s leading position in this market is attributed to its strong geographical presence and wide product portfolio, which includes insulin pumps, smart glucose meters, CGM systems, mobile applications, data management software, and services.